Lazard Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-6,939
Closed -$48.6K – 2077
2025
Q4
$48.6K Hold
6,939
– – ﹤0.01% 1796
2025
Q3
$53.6K Buy
6,939
+66
+1% +$515 ﹤0.01% 1736
2025
Q2
$59K Buy
+6,873
New +$49.8K ﹤0.01% 1977
2024
Q3
– Sell
-340
Closed -$3K – 2453
2024
Q2
$3K Sell
340
-1
-0.3% -$12 ﹤0.01% 2092
2024
Q1
$5K Sell
341
-3,090
-90% -$56.1K ﹤0.01% 1901
2023
Q4
$73K Buy
3,431
+232
+7% +$4.28K ﹤0.01% 1786
2023
Q3
$59K Sell
3,199
-130,780
-98% -$3.05M ﹤0.01% 1807
2023
Q2
$3.39M Buy
+133,979
New +$3.37M ﹤0.01% 782
2023
Q1
– Sell
-305
Closed -$7K – 2545
2022
Q4
$7K Hold
305
– – ﹤0.01% 2237
2022
Q3
$7K Sell
305
-833
-73% -$29.2K ﹤0.01% 2172
2022
Q2
$37K Sell
1,138
-111
-9% -$4.71K ﹤0.01% 1942
2022
Q1
$90K Sell
1,249
-55
-4% -$3.96K ﹤0.01% 1437
2021
Q4
$119K Sell
1,304
-5,995
-82% -$717K ﹤0.01% 1394
2021
Q3
$925K Buy
+7,299
New +$1.06M ﹤0.01% 1079
2021
Q2
– Sell
-41,260
Closed -$7.5M – 2071
2021
Q1
$7.5M Sell
41,260
-8,026
-16% -$1.86M 0.01% 609
2020
Q4
$9.86M Buy
+49,286
New +$10M 0.01% 560
2020
Q3
– Sell
-241
Closed -$45K – 1738
2020
Q2
$45K Buy
+241
New +$42.2K ﹤0.01% 1255

Other funds holding TDOC

Lazard Asset Management's TDOC Position: Q1 2026 in Review

Lazard Asset Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 6,939 shares — an estimated $48.6K sold.

Lazard Asset Management first reported a position in TDOC in Q2 2020 and held it in 17 quarters. The position peaked at $9.86M in Q4 2020. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Lazard Asset Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 6,939 Teladoc Health shares in Q1 2026, an estimated $48.6K.
  • Lazard Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 17 quarters.
  • Lazard Asset Management's Teladoc Health position peaked at $9.86M in Q4 2020.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.